Development of Transdiagnostic Single-session Treatment
- Conditions
- Stress DisorderDepressionAnxiety Disorders
- Interventions
- Behavioral: Transdiagnostic single-session treatment
- Registration Number
- NCT05784259
- Lead Sponsor
- Luleå Tekniska Universitet
- Brief Summary
The goal of this clinical trial is to test a single session treatment program in primary care patients with anxiety and/or depression and/or stress-related issues. The main questions it aims to answer is:
* Will the transdiagnostic treatment program decrease symptoms of depression/anxiety/stress?
* Will the transdiagnostic treatment program decrease transdiagnostic risk factors?
* Will the transdiagnostic treatment program decrease the measured risk factors equally?
* Will the transdiagnostic treatment program impact patients with anxiety, depression or stress disorders equally?
* Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on transdiagnostic risk factors?
* Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on anxiety, depression, or stress-symptoms?
* Have the participants been able to generalize the skills taught in the program(qualitative)?
* Within group that were treated with single-session treatment and recieved additional care before follow-up, was there a difference in outcome?
- Detailed Description
The study investigates the effect of a single-session, 4 hour, transdiagnostic treatment for primary care patientst with depression, anxiety or stress.
The treatment includes, interoceptive exposure, behavioral activation, mindfulness, defusion and psycho-education about emotions.
The study is conducted in a clinical setting in northern sweden and follows up results at 3 weeks and 6 months post treatment.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 300
- Meet the criteria for anxiety, mood disorder, or stress diagnosis
- Symptoms are mild to moderate in severity
- Already in ongoing psychotherapy
- Within a month commenced pharmaceutical treatment that will likely impact mood or psychological functioning and is not deemed to be on a stable dose
- Has a comorbid personality disorder
- Has a risk of suicide deemed other than low
- Has other severe psychological disorders outside the scope of primary care
- Is in a severely stressful social situation deemed incompatible with psychotherapy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment group Transdiagnostic single-session treatment Transdiagnostic single-session treatment
- Primary Outcome Measures
Name Time Method Mindfulness post-treatment 3 weeks post-treatment Measured using FFMQ, mindfulness
Alexithymia post-treatment 3 weeks post-treatment Measured using TAS-20, mindfulness
Generalization 6 months post-treatment Qualitative interview with a few selected patients to review their experience of the treatment, its effectiveness and their ability to use the techniques taught.
Anxiety, Depression and Stress symptoms post-treatment 3 weeks post-treatment Measured using DASS-21
Anxiety sensitivity post-treatment 3 weeks post-treatment Measured using BSQ, fear of bodily sensations related to anxiety
Experiential avoidance post-treatment 3 weeks post-treatment Measured using AFQ-Y8, psychological flexibility
Experiential avoidance follow-up 6 months post-treatment Measured using AFQ-Y8, psychological flexibility
Alexithymia follow-up 6 months post-treatment Measured using TAS-20, mindfulness
Anxiety, Depression and Stress symptoms follow-up 6 months post-treatment Measured using DASS-21
Anxiety sensitivity follow-up 6 months post-treatment Measured using BSQ, fear of bodily sensations related to anxiety
Mindfulness follow-up 6 months post-treatment Measured using FFMQ, mindfulness
- Secondary Outcome Measures
Name Time Method Additional treatment 6 months post-treatment It will be recorded if patients sought additional care after single-session treatment as well as type of care.
Trial Locations
- Locations (1)
Region Norrbotten, Primary care
🇸🇪Luleå, Norrbotten, Sweden